Troy Edward Wilson Buys $1.5M of Kura Oncology Inc (KURA) — SEC Form 4, Nov 17, 2026
Open-Market Net Purchase · SEC Form 4
+$1,504,765
Equity position changed by +16.5%
Equity Position
1.41M sh
1,214,650 → 1,414,650
Equity Change
+16.5%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Troy Edward Wilson CIK 0001589597 |
Director
CEO
|
Troy Edward Wilson at Kura Oncology Inc
Full insider history
Bought (12 mo)
$3,855,765
Sold (12 mo)
—
More from this insider at Kura Oncology Inc
| 2026-08-24 | Buy | +$1,239,000 | View |
| 2026-08-17 | Buy | +$1,112,000 | View |
| 2026-03-25 | Exercise | — | View |
| 2026-01-06 | Award | — | View |
| 2025-11-14 | Award | — | View |
Non-Derivative Securities Transactions
Non-Derivative Holdings
| Title | Shares Held | Ownership |
|---|---|---|
| Common Stock | 479,194 | Indirect by One Fish Two Fish Revocable Trust |
| Common Stock | 300,000 | Indirect by Lorax Charitable Remainder Unitrust |
Footnotes (2)
- F1
- This transaction was executed in multiple trades at prices ranging from $7.47 to $7.79. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Show more
- F2
- This transaction was executed in multiple trades at prices ranging from $7.27 to $7.73. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Show more
Related filings at Kura Oncology Inc
Institutional Holders
13F holders · Sep 30, 2026
229
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $126M
- Suvretta Capital Management, Llc $84.6M
- Bvf Inc/Il $71.7M
5%+ Holders · 13D/G
5 filers
Other insiders at Kura Oncology Inc
-
Kathleen Ford -$112K
-
Mollie Leoni -$440K
-
Brian T. Powl -$345K
-
Teresa Brophy Bair -$88.6K
-
Thomas James Doyle -$48.4K
GET /v1/forms/4/0001193125-26-464166
API docs
View Original SEC Filing